Results 91 to 100 of about 9,051 (207)

Certification of the industry reference standard for the specific activity of «BiVac polio» - live attenuated bivalent oral polio vaccine type 1 and 3

Биопрепараты: Профилактика, диагностика, лечение, 2018
The standardization and control of «BiVac polio» (live attenuated bivalent oral polio vaccine type 1 and 3) developed by M. P. Chumakov Institute of Poliomyelitis and Viral Encephalitides of the Russian Academy of Medical Sciences, called for ...
E. V. Karpova, A. D. Sangadzhieva, T. V. Mamontova, O. V. Fadeykina, R. A. Volkova, K. A. Sarkisyan, A. A. Movsesyants   +6 more
doaj  

Polio eradication in Ghana: past, present, and future

Frontiers in Tropical Diseases
IntroductionGhana joined the Global Polio Eradication Initiative in 1996 to interrupt wild poliovirus transmission in the country. This was a collaborative effort by the Ghana Health Service (Disease Surveillance Department and the Expanded Program on ...
John Kofi Odoom, Dennis Odai Laryea, Nana Afia Asante Ntim, Keren Attiku, Michael Adjabeng, Ewurabena Oduma Duker, Comfort Nuamah Antwi, Emmanuel Gberbi, Isaac Baffoe-Nyarko, Patience Lartekai Adams, Angelina Evelyn Dickson, Jessica Dufie Boakye, Jude Yayra Mensah, Christabel Odoom, Sharon Ansong Bimpong, Deborah Odame, Gayheart Deladem Agboste, Nancy Odoom, Franklin Asiedu-Bekoe, Evangeline Obodai   +19 more
doaj   +1 more source

Polio: Background and perspective on how international travel can be made safe against polio

Therapeutic Advances in Infectious Disease
International spread of polio continues to be a Public Health Emergency of International Concern since its declaration by the World Health Organization in 2014 and its reiteration in 2024.
Dhanya Dharmapalan, Thekkekara Jacob John, Robert Steinglass, Norbert Hirschhorn   +3 more
doaj   +1 more source

Advances and challenges in poliomyelitis vaccines: a comprehensive review of development, production, and global deployment

Frontiers in Public Health
Poliomyelitis has been a significant global health challenge for centuries. Since the launch of the Global Polio Eradication Initiative (GPEI) in 1988, remarkable progress has been achieved, with wild poliovirus (WPV) cases reduced by over 99%.
Jia Liang, Qi Zhang, Yanan Li, Lili Wang
doaj   +1 more source

Viral Aetiology of Acute Flaccid Paralysis Surveillance Cases, before and after Vaccine Policy Change from Oral Polio Vaccine to Inactivated Polio Vaccine

Journal of Tropical Medicine, 2014
Since 1992, surveillance for acute flaccid paralysis (AFP) cases was introduced in Malaysia along with the establishment of the National Poliovirus Laboratory at the Institute for Medical Research.
T. S. Saraswathy Subramaniam, Mohd Apandi Apandi, Rohani Jahis, Mohd Samsul Samsudin, Zainah Saat   +4 more
doaj   +1 more source

The effect of azithromycin on the immunogenicity of oral poliovirus vaccine: a double-blind randomised placebo-controlled trial in seronegative Indian infants.

, 2016
Oral poliovirus vaccine is less immunogenic and effective in low-income countries than in high-income countries, similarly to other oral vaccines. The high prevalence of intestinal pathogens and associated environmental enteropathy has been proposed to ...
Balakumar, Shailaja, Houpt, Eric R, Iturriza-Gómara, M, Uhlig, Holm, Parker, EPK, Uhlig, Holm H, Venugopal, Srinivasan, Liu, Jie, Bahl, S, Giri, Sidhartha, Praharaj, Ira, Jeyapaul, Shalini, Parker, Edward P.K., Srinivasan, Rajan, Muliyil, Jayaprakash, John, J, Raman, Uma, Uhlig, HH, Grassly, Nicholas C, Abraham, Asha, Ravikumar, Jeniffer, John, Jacob, Doss, S, Raman, U, Abraham, A, Babji, S, Jeyapaul, S, Ravikumar, J, Doss, Sridhar, Srinivasan, R, Parker, EP, Muliyil, J, Paranjape, Meghana, Kang, Gagandeep, Bahl, Sunil, Iturriza-Gómara, Miren, Babji, Sudhir, Peter, John Victor, Parker, Edward P K, Grassly, NC, Grassly, Nicholas C., Houpt, ER, Houpt, Eric R., Kaliappan, Saravanakumar Puthupalayam, Peter, JV, Kaliappan, SP, Praharaj, I, Venugopal, S, Liu, J, Kang, G, Giri, S, Paranjape, M, Balakumar, S   +52 more
core   +1 more source

Impediments to Progress Toward Polio Eradication During 2014–2024: Effectively Addressing the Current Challenges

Vaccines
When the Global Polio Eradication Initiative (GPEI) began in 1988, the year 2000 target was clearly ambitious. Nonetheless, among 20 countries with endemic wild poliovirus transmission in 2000, only Afghanistan, Nigeria and Pakistan remained endemic in ...
Steven G. F. Wassilak, Abdinoor Mohamed, John Paul Bigouette   +2 more
doaj   +1 more source

Novel Oral Polio Vaccine Type 2 Use for Polio Outbreak Response: A Global Effort for a Global Health Emergency

Pathogens
A sharp rise in circulating vaccine-derived poliovirus type 2 (cVDPV2) outbreaks in the years following the cessation of routine use of poliovirus type 2-containing oral polio vaccine and the trend of seeding new emergences with suboptimal vaccination ...
Feyrouz Damji Kurji, Ananda Sankar Bandyopadhyay, Simona Zipursky, Laura V. Cooper, Chris Gast, Margaret Toher, Ralf Clemens, Sue Ann Costa Clemens, Rayasam Prasad, Adriansjah Azhari   +9 more
doaj   +1 more source

Oral Poliovirus Vaccine Evolution and Insights Relevant to Modeling the Risks of Circulating Vaccine-Derived Polioviruses (cVDPVs)

, 2013
The live, attenuated oral poliovirus vaccine (OPV) provides a powerful tool for controlling and stopping the transmission of wild polioviruses (WPVs), although the risks of vaccine-associated paralytic polio (VAPP) and circulating vaccine-derived ...

core   +1 more source

Antiviral Development for the Polio Endgame: Current Progress and Future Directions

Pathogens
As the world is approaching the eradication of wild poliovirus serotype 1, the last of the three wild types, the question of how to maintain a polio-free world becomes imminent.
Hang Xie, Eric E. Rhoden, Hong-Mei Liu, Folake Ogunsemowo, Bernardo A. Mainou, Rachel M. Burke, Cara C. Burns   +6 more
doaj   +1 more source